The effect of renal stones on serum adenosine aminohydrolase and AMP-aminohydrolase in Malaysia
10.1016/j.apjtb.2015.04.003
- Author:
Faridah YUSOF
1
;
Atheer Awad MEHDE
1
;
Atheer Awad MEHDE
2
;
Wesen ADEL MEHDI
3
;
Hamid GHAZALI
4
;
Azlina ABD RAHMAN
5
Author Information
1. Department of Biotechnology Engineering, College of Engineering, International Islamic University Malaysia
2. Department of Medical Analysis, Health and Medical Technical College
3. Department of Chemistry, College of Sciences for Women, University of Baghdad
4. Department of Urology, Hospital Tengku Ampuan Afzan
5. Department of Pathology, Hospital Tengku Ampuan Afzan
- Publication Type:Journal Article
- Keywords:
Adenosine aminohydrolase;
AMP-aminohydrolase;
Renal stone;
Uric acid
- From:Asian Pacific Journal of Tropical Biomedicine
2015;5(6):478-484
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To verify possible associations between adenosine aminohydrolase (ADA) and AMP-aminohydrolase (AMPDA) to E3 SUMO-protein ligase NSE2 (NSMCE2) in patients with renal stones. And to isolate, purify and characterize ADA in patients with renal stones and healthy group. Methods: A total of 60 renal stones patients and 50 control were enrolled in a case- control study. The blood urea, creatinine, uric acid, protein, albumin, ADA and AMPDA were measured by colorimetric tests. The serum NSMCE2 was measured by ELISA. Results: Serum ADA, AMPDA and specific activity of enzymes showed significant decrease (P < 0.05) in patients with renal stones compared to control group, mean levels of sera NSMCE2 and uric acid had a significant increase (P < 0.01 and P < 0.05, respectively) in patients compared to control group. Conclusions: The present study suggests that ADA, AMP deaminase and NSMCE2 can be used as a indicator to monitor the DNA damage and inflammation disorders in the patients with kidney stones.
